NBD AI Bulletin - Guangzhou Kingmed Diagnostics Group Co Ltd ("the Company", SH 603882, closing price: 99.5 yuan) announced on late December 11 that shareholder Guangzhou Shengyufang Investment Management (L.P.) pledged 4.55 million shares on December 10, 2020, accounting for 21.67% of its holdings. Guangzhou Shengyufang Investment Management (L.P.) directly holds 21 million shares without restrictions on sale, which represent 4.57% of the Company's total equity.

After the pledge, Guangzhou Shengyufang Investment Management (L.P.) and the Company's controlling shareholder and actual controller Mr. Liang Yaoming and persons acting in concert Mr. Zeng Zhanwen and Ms. Yan Ting pledged 31.17 million shares accumulatively, accounting for 31.46% of the Company's total shares or 6.78% of the Company's total equity.

The 2019 annual report shows that Guangzhou Kingmed Diagnostics Group Co Ltd mainly engages in third-party medical diagnosis, accounting for 94.22% of its revenue.

Guangzhou Kingmed Diagnostics Group Co Ltd's general manager and chairman is Liang Yaoming, male, 56 years old, Chinese national, no overseas permanent residency, MBA.

Tips on "Stock Trends":

1. The number of shares held by northbound investors in the Company increased by 2.8659 million in the past 30 days, representing 0.63% of the Company's circulating shares;

2. There was no institutional research on the Company in the past 30 days.  

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.